Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Validity of wrist-worn consumer products to measure heart rate and energy expenditure.

Thiebaud RS, Funk MD, Patton JC, Massey BL, Shay TE, Schmidt MG, Giovannitti N.

Digit Health. 2018 Apr 13;4:2055207618770322. doi: 10.1177/2055207618770322. eCollection 2018 Jan-Dec.

2.

Analyzing Dental Students' Clinic Production Using Time-Based Relative Value Units: Ten-Year Cross-Cohort Mapping.

Watkins RT Jr, Conn LJ, Gellin RG, Gonzales TS, Hamil LM, Cayouette MJ, Schmidt MG.

J Dent Educ. 2018 Mar;82(3):260-268. doi: 10.21815/JDE.018.025.

PMID:
29496804
3.

Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review - a different view.

Schmidt MG, Salgado CD, Freeman KD, John JF, Cantey JR, Sharpe PA, Michels HT.

J Hosp Infect. 2018 Jul;99(3):309-311. doi: 10.1016/j.jhin.2018.02.007. Epub 2018 Feb 12. No abstract available.

PMID:
29448050
4.

Antimicrobial copper alloys decreased bacteria on stethoscope surfaces.

Schmidt MG, Tuuri RE, Dharsee A, Attaway HH, Fairey SE, Borg KT, Salgado CD, Hirsch BE.

Am J Infect Control. 2017 Jun 1;45(6):642-647. doi: 10.1016/j.ajic.2017.01.030. Epub 2017 Mar 13.

5.

Copper alloy surfaces sustain terminal cleaning levels in a rural hospital.

Hinsa-Leasure SM, Nartey Q, Vaverka J, Schmidt MG.

Am J Infect Control. 2016 Nov 1;44(11):e195-e203. doi: 10.1016/j.ajic.2016.06.033. Epub 2016 Sep 28.

6.

Perspectives from the field in response to "It is time to revise our approach to registering antimicrobial agents for health care settings".

Schmidt MG, John JJ Jr, Freeman KD, Sharpe PA, Estelle AA, Michels HT.

Am J Infect Control. 2016 Oct 1;44(10):1187-1189. doi: 10.1016/j.ajic.2016.04.249. Epub 2016 Aug 9. No abstract available.

PMID:
27520787
7.

Potential effectiveness of copper surfaces in reducing health care-associated infection rates in a pediatric intensive and intermediate care unit: A nonrandomized controlled trial.

von Dessauer B, Navarrete MS, Benadof D, Benavente C, Schmidt MG.

Am J Infect Control. 2016 Aug 1;44(8):e133-9. doi: 10.1016/j.ajic.2016.03.053. Epub 2016 Jun 16.

8.

Antibacterial Diamines Targeting Bacterial Membranes.

Wang B, Pachaiyappan B, Gruber JD, Schmidt MG, Zhang YM, Woster PM.

J Med Chem. 2016 Apr 14;59(7):3140-51. doi: 10.1021/acs.jmedchem.5b01912. Epub 2016 Mar 28.

9.

Copper surfaces are associated with significantly lower concentrations of bacteria on selected surfaces within a pediatric intensive care unit.

Schmidt MG, von Dessauer B, Benavente C, Benadof D, Cifuentes P, Elgueta A, Duran C, Navarrete MS.

Am J Infect Control. 2016 Feb;44(2):203-9. doi: 10.1016/j.ajic.2015.09.008. Epub 2015 Nov 6.

10.

From Laboratory Research to a Clinical Trial: Copper Alloy Surfaces Kill Bacteria and Reduce Hospital-Acquired Infections.

Michels HT, Keevil CW, Salgado CD, Schmidt MG.

HERD. 2015 Fall;9(1):64-79. doi: 10.1177/1937586715592650. Epub 2015 Jul 10.

11.

Intereukin-10 and Kupffer cells protect steatotic mice livers from ischemia-reperfusion injury.

Sutter AG, Palanisamy AP, Ellet JD, Schmidt MG, Schnellmann RG, Chavin KD.

Eur Cytokine Netw. 2014 Oct-Dec;25(4):69-76. doi: 10.1684/ecn.2015.0359.

12.

Mitochondrial uncoupling protein 2 induces cell cycle arrest and necrotic cell death.

Palanisamy AP, Cheng G, Sutter AG, Evans ZP, Polito CC, Jin L, Liu J, Schmidt MG, Chavin KD.

Metab Syndr Relat Disord. 2014 Mar;12(2):132-42. doi: 10.1089/met.2013.0096. Epub 2013 Dec 9.

13.

Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice.

Cheng G, Palanisamy AP, Evans ZP, Sutter AG, Jin L, Singh I, May H, Schmidt MG, Chavin KD.

PLoS One. 2013 Sep 27;8(9):e75980. doi: 10.1371/journal.pone.0075980. eCollection 2013.

14.

Reply to Harbarth et al.

Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):997-9. doi: 10.1086/671938. No abstract available.

PMID:
23917920
15.

Copper continuously limits the concentration of bacteria resident on bed rails within the intensive care unit.

Schmidt MG, Attaway Iii HH, Fairey SE, Steed LL, Michels HT, Salgado CD.

Infect Control Hosp Epidemiol. 2013 May;34(5):530-3. doi: 10.1086/670224.

PMID:
23571374
16.

Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit.

Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG.

Infect Control Hosp Epidemiol. 2013 May;34(5):479-86. doi: 10.1086/670207.

PMID:
23571364
17.

Characterization and control of the microbial community affiliated with copper or aluminum heat exchangers of HVAC systems.

Schmidt MG, Attaway HH, Terzieva S, Marshall A, Steed LL, Salzberg D, Hamoodi HA, Khan JA, Feigley CE, Michels HT.

Curr Microbiol. 2012 Aug;65(2):141-9. doi: 10.1007/s00284-012-0137-0. Epub 2012 May 9.

18.

Sustained reduction of microbial burden on common hospital surfaces through introduction of copper.

Schmidt MG, Attaway HH, Sharpe PA, John J Jr, Sepkowitz KA, Morgan A, Fairey SE, Singh S, Steed LL, Cantey JR, Freeman KD, Michels HT, Salgado CD.

J Clin Microbiol. 2012 Jul;50(7):2217-23. doi: 10.1128/JCM.01032-12. Epub 2012 May 2.

19.

Intrinsic bacterial burden associated with intensive care unit hospital beds: effects of disinfection on population recovery and mitigation of potential infection risk.

Attaway HH 3rd, Fairey S, Steed LL, Salgado CD, Michels HT, Schmidt MG.

Am J Infect Control. 2012 Dec;40(10):907-12. doi: 10.1016/j.ajic.2011.11.019. Epub 2012 Feb 22.

PMID:
22361357
21.

Evaluation of the antimicrobial properties of copper surfaces in an outpatient infectious disease practice.

Rai S, Hirsch BE, Attaway HH, Nadan R, Fairey S, Hardy J, Miller G, Armellino D, Moran WR, Sharpe P, Estelle A, Michel JH, Michels HT, Schmidt MG.

Infect Control Hosp Epidemiol. 2012 Feb;33(2):200-1. doi: 10.1086/663701. Epub 2011 Dec 27. No abstract available.

PMID:
22227992
22.

Mitochondrial uncoupling protein-2 deficiency protects steatotic mouse hepatocytes from hypoxia/reoxygenation.

Evans ZP, Palanisamy AP, Sutter AG, Ellett JD, Ramshesh VK, Attaway H, Schmidt MG, Schnellmann RG, Chavin KD.

Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1;302(3):G336-42. doi: 10.1152/ajpgi.00049.2011. Epub 2011 Nov 17.

23.

Patient environment microbial burden reduction: a pilot study comparison of 2 terminal cleaning methods.

Schmidt MG, Anderson T, Attaway HH 3rd, Fairey S, Kennedy C, Salgado CD.

Am J Infect Control. 2012 Aug;40(6):559-61. doi: 10.1016/j.ajic.2011.07.013. Epub 2011 Oct 5.

PMID:
21981792
24.

Toll-like receptor 4 knockout mice are protected from endothelial overactivation in the absence of Kupffer cells after total hepatic ischemia/reperfusion.

Ellett JD, Atkinson C, Evans ZP, Amani Z, Balish E, Schmidt MG, Schnellmann RG, Chavin KD.

Liver Transpl. 2011 Sep;17(9):1089-98. doi: 10.1002/lt.22333.

25.

Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10.

Ellett JD, Atkinson C, Evans ZP, Amani Z, Balish E, Schmidt MG, van Rooijen N, Schnellmann RG, Chavin KD.

J Immunol. 2010 May 15;184(10):5849-58. doi: 10.4049/jimmunol.0902024. Epub 2010 Apr 16.

26.

Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion.

Evans ZP, Mandavilli BS, Ellett JD, Rodwell D, Fariss MW, Fiorini RN, Schnellmann RG, Schmidt MG, Chavin K.

Transplant Proc. 2009 Dec;41(10):4094-8. doi: 10.1016/j.transproceed.2009.09.055.

27.

Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.

Ellett JD, Evans ZP, Atkinson C, Schmidt MG, Schnellmann RG, Chavin KD.

Liver Transpl. 2009 Sep;15(9):1101-9. doi: 10.1002/lt.21782.

28.

Vitamin E succinate reduces ischemia/reperfusion injury in steatotic livers.

Evans ZP, Ellett JD, Fariss MW, Schnellmann RG, Schmidt MG, Chavin K.

Transplant Proc. 2008 Dec;40(10):3327-9. doi: 10.1016/j.transproceed.2008.06.076.

29.

The use of the Papworth cocktail is detrimental to steatotic livers after ischemia-reperfusion injury.

Ellett JD, Evans ZP, Fiorini JH, Fiorini RN, Haines JK, Schmidt MG, Chavin KD.

Transplantation. 2008 Jul 27;86(2):286-92. doi: 10.1097/TP.0b013e31817b900f.

30.

Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion.

Evans ZP, Ellett JD, Schmidt MG, Schnellmann RG, Chavin KD.

J Biol Chem. 2008 Mar 28;283(13):8573-9. Epub 2007 Dec 17.

31.

Reaction-subdiffusion equations.

Sokolov IM, Schmidt MG, Sagués F.

Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Mar;73(3 Pt 1):031102. Epub 2006 Mar 2.

PMID:
16605495
32.

Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.

Fiorini RN, Donovan JL, Rodwell D, Evans Z, Cheng G, May HD, Milliken CE, Markowitz JS, Campbell C, Haines JK, Schmidt MG, Chavin KD.

Liver Transpl. 2005 Mar;11(3):298-308.

33.

Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice.

Fiorini RN, Shafizadeh SF, Polito C, Rodwell DW, Cheng G, Evans Z, Wan C, Belden S, Haines JK, Birsner J, Lewin D, Wasiluk KR, Dunn DL, Schmidt MG, Chavin KD.

Am J Transplant. 2004 Oct;4(10):1567-73.

34.

Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation.

Chavin KD, Fiorini RN, Shafizadeh S, Cheng G, Wan C, Evans Z, Rodwell D, Polito C, Haines JK, Baillie GM, Schmidt MG.

Am J Transplant. 2004 Sep;4(9):1440-7.

35.

Steatotic liver transplantation in the mouse: a model of primary nonfunction.

Birsner JH, Wan C, Cheng G, Evans ZP, Polito CC, Fiorini RN, Gilbert G, Haines JK, Schmidt MG, Chavin KD.

J Surg Res. 2004 Jul;120(1):97-101.

PMID:
15172195
36.

Coherent baryogenesis.

Garbrecht B, Prokopec T, Schmidt MG.

Phys Rev Lett. 2004 Feb 13;92(6):061303. Epub 2004 Feb 13.

PMID:
14995229
37.

Decrease of intracellular ATP content downregulated UCP2 expression in mouse hepatocytes.

Cheng G, Polito CC, Haines JK, Shafizadeh SF, Fiorini RN, Zhou X, Schmidt MG, Chavin KD.

Biochem Biophys Res Commun. 2003 Aug 29;308(3):573-80.

PMID:
12914789
38.

Development of a thermally regulated broad-spectrum promoter system for use in pathogenic gram-positive species.

Schofield DA, Westwater C, Hoel BD, Werner PA, Norris JS, Schmidt MG.

Appl Environ Microbiol. 2003 Jun;69(6):3385-92.

39.

Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, Norris JS.

Antimicrob Agents Chemother. 2003 Apr;47(4):1301-7.

40.

Effectiveness of participation as a defendant: the attorney-juvenile client relationship.

Schmidt MG, Reppucci ND, Woolard JL.

Behav Sci Law. 2003;21(2):175-98.

PMID:
12645044
41.

Doc-mediated cell killing in Shigella flexneri using a C1/LacI controlled expression system.

Schofield DA, Westwater C, Dolan JW, Norris JS, Schmidt MG.

FEMS Microbiol Lett. 2002 Oct 8;215(2):237-42.

42.

Cloning, expression, and functional characterization of the Mycobacterium tuberculosis secA gene.

Owens MU, Swords WE, Schmidt MG, King CH, Quinn FD.

FEMS Microbiol Lett. 2002 Jun 4;211(2):133-41.

43.

Tandem biodegradation of BTEX components by two Pseudomonas sp.

Attaway HH, Schmidt MG.

Curr Microbiol. 2002 Jul;45(1):30-6.

PMID:
12029524
44.

Tight regulation and modulation via a C1-regulated promoter in Escherichia coli and Pseudomonas aeruginosa.

Schofield DA, Westwater C, Dolan JW, Norris JS, Schmidt MG.

Curr Microbiol. 2002 Jun;44(6):425-30.

PMID:
12000993
45.

Overcoming the phage replication threshold: a mathematical model with implications for phage therapy.

Kasman LM, Kasman A, Westwater C, Dolan J, Schmidt MG, Norris JS.

J Virol. 2002 Jun;76(11):5557-64.

46.

Comparison of microporous and nonporous membrane bioreactor systems for the treatment of BTEX in vapor streams.

Attaway H, Gooding CH, Schmidt MG.

J Ind Microbiol Biotechnol. 2002 May;28(5):245-51.

PMID:
11986927
47.

Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria.

Westwater C, Schofield DA, Schmidt MG, Norris JS, Dolan JW.

Microbiology. 2002 Apr;148(Pt 4):943-50.

PMID:
11932441
48.

Controlled expression in Klebsiella pneumoniae and Shigella flexneri using a bacteriophage P1-derived C1-regulated promoter system.

Schofield DA, Westwater C, Dolan JW, Schmidt MG, Norris JS.

J Bacteriol. 2001 Dec;183(23):6947-50.

49.
50.

Biodegradation of BTEX vapors in a silicone membrane bioreactor system.

Attaway H, Gooding CH, Schmidt MG.

J Ind Microbiol Biotechnol. 2001 May;26(5):316-25.

PMID:
11494109

Supplemental Content

Loading ...
Support Center